Dr. Andreas Nechansky has taken over the role of Managing Director of ABF Pharmaceutical Services (Member of GBAGroup). Dr. Nechansky has proven his management skills as Site Manager of ABF since 2019, and brings over 20 years’ experience in the field of Pharmaceutical Development and biologics characterization.

As VP of Research and Analytical Development of JHL Biotech (Taiwan), he became an expert in biosimilar development spanning pre-clinical work to Phase III readiness, including overseeing and directing bioanalytical and immunogenicity operations. As co-founder and COO of Vela Laboratories, he was responsible for Business Development and GMP-certified analytical operations services. Work as Head Analytical Development at Igeneon and postdoctoral positions at the Scripps Research Institute and at Novartis followed his PhD in Molecular Genetics from the University of Vienna. Dr. Nechansky is author of over 20 publications and familiar with all stages of new drug development, including the requirements of GMP. His vision is to position ABF as a trusted and renowned key player in clinical trial logistics and harmonized PBMC network activities.